Sharpe
Senior Moderator
Re: Discussion on Indonesia Outbreaks
My understanding is that it is small--which is why the Australian company that patented it is suing GSK. Additionally, it should be noted that Relenza is an inhalable drug and is only available to the lung tissue itself. Any infection that is in the blood or other organs would be virtually inaccessible by the drug at least at therapeutic levels, anyway.Snowy Owl said:Thank you Doctor Niman,
This raise some question for Indonesia. Does anybody know Relenza production capacity by GlaxoSmithKline??